Get the latest news and updates
Sam returned to Agilent in 2017 after a decade of business leadership roles at other notable life science companies. He joined to manage the Strategy and Corporate Development function and led the creation of Agilent's first long range strategy while strengthening Agilent's M&A capabilities and overseeing a number of acquisitions that strategically enhanced Agilent's offerings to customers. Prior to re-joining Agilent, Sam was vice president of global marketing at Illumina, a San Diego-based life sciences company. He was responsible for all aspects of marketing including product management, clinical and corporate marketing, digital experience, marketing operations and strategy. He led the successful go-to-market strategy and launch of many impactful products, including multiple sequencing systems and consumables. Earlier in his career Sam was vice president and general manager of Agilent's Americas Field Operations with responsibility for sales, regional marketing, customer and applications support for the Life Sciences and Chemical Analysis Group, a position he held from 2004-2007.
Revolutionary technologies, machines and applications allow NGS to lead scientific advancement and reach the clinic. This momentum has increased in the past year. In this session, we will hear from several large NGS manufacturers and process pipelines about their current goals, upcoming developments and what the future holds for their products.